Feature

Medical and Surgical Management of Bladder Outlet Obstruction

Treatment of LUTS secondary to BPH has evolved from surgical therapy to medical monotherapy, and now combination therapy.

Adrenal Masses: Often Incidental, Not Always Insignificant

Given the frequency with which these lesions are found, urologists and nephrologists should be familiar with their evaluation.

Uric Acid and the Kidney - Is There a Role for Urate Lowering?

Uric Acid and the Kidney - Is There a Role for Urate Lowering? By

Many but not all cohort studies examining the relationship between hyperuricemia and CKD outcomes suggest they may be intertwined.

Thyroid Functional Disease in Dialysis Patients

Emerging data suggest that thyroid hormone deficiency may be associated with 
greater cardiovascular morbidity and mortality in this population.

The Pros and Cons of Vitamin D Supplementation

By

In both nutritional and activated forms, vitamin D may have side effects that are as yet under-appreciated.

Transplants Candidates: How Much Does Size Matter?

Transplants Candidates: How Much Does Size Matter? By

Obese individuals often are rejected as renal transplant candidates in large part because of their increased risk for surgical complications and adverse outcomes.

Pre-treatment Percutaneous Biopsy of Small Renal Masses

Urologists typically treat a renal cortical mass without biopsy, but this should be re-evaluated in the era of the incidental small renal cortical neoplasm.

The Association Between Kidney Failure and Renal Cell Carcinoma

Scientific speculation suggests that uremic toxins, viral mediators, and immune ­inhibition could play a role in malignant transformation.

Current Controversies Surrounding PSA Screening

It is hoped that selective screening, selective biopsy, and selective therapy will 
further decrease the morbidity associated with screening.

Nonmuscle Invasive Bladder Cancer: Guidelines for Treatment

The routine incorporation of NMIBC clinical practice guidelines will reduce variation in care by closing the gap on inappropriate delivery, whether over- or underuse.

Fabry Disease: The Nephrologist's Role

Fabry Disease: The Nephrologist's Role By

The complex disease requires regular follow up and assessment of the ongoing response to therapy.

The Evaluation and Treatment of Resistant Hypertension

With increased incidence of obesity—and higher caloric and salt intake—in the general population, resistant hypertension is more prevalent than ever.

Adrenal Hypertension: A Current Guide to Diagnosis

Given the intimate anatomical and physiological relationship of the adrenals to the kidney, an understanding of adrenal disease is imperative for urologists and nephrologists alike.

An Update: Radiation or Surgery for Prostate Cancer

The management of patients with high-risk prostate cancer represents one of the ­biggest challenges today, with little consensus on optimal treatment.

Part II: Current Treatment Options for Neurogenic Bladder Dysfunction

Clinicians need to keep abreast of the most current treatment options for NGB, which can result in improved patient outcomes and quality of life.

Renal Protection Through BP Control

By By

Despite recent advances in the treatment of hypertension, the majority of patients with chronic kidney disease (CKD) still remain above current blood pressure (BP) targets.

Part III: Clinical Challenges and Renal Considerations in Managing Gout

A case study involving a 58-year-old man with acute gout attacks and multiple ­comorbidities, including hypertension and hypercholesterolemia.

An Update on the Management of Lupus Nephritis

Approximately 30%-50% of SLE patients have clinically evident renal disease at ­presentation, but renal involvement occurs in up to 60% of patients overall.

Part I: Assessment and Diagnostic Strategies for Neurogenic Bladder

Diagnostics and treatment options for NGB are continually advancing, and clinicians need to remain up-to-date to accurately assess and optimally manage patients

Managing Bone Disease in Kidney Transplant Recipients

Pre-existing renal osteodystrophy at the time of transplantation, reduced renal 
function, and transplantation-specific therapies are the main contributing factors.

Setting Up a Home Hemodialysis Program

Setting Up a Home Hemodialysis Program By

As you develop and grow a home HD program, not only will you have wonderful successes, but there will also be challenges and disappointments.

Part II: Clinical Challenges and Renal Considerations in Managing Gout

A case study involving a 65-year-old man with chronic kidney disease and acute attacks of pain, swelling, and erythema in the first metatarsophalangeal joint.

The Impact of Bundling on Clinical Practice

The Impact of Bundling on Clinical Practice By

This is the title of a scheduled May 12 session at the National Kidney Foundation's 2012 Spring Clinical Meetings.

Clinical Challenges and Renal Considerations In Managing Gout

A case study examines the treatment of hyperuricemia and gout in a 57-year-old postmenopausal renal transplant recipient with intermittent gout attacks.

Lessons from "The Hemodialysis Marathon Man"

Lessons from "The Hemodialysis Marathon Man" By

An impressive story of a dialysis survivor who watched his daughters grow and getting married, and had the joy of knowing several grandchildren.

The Management of Patients After Renal Transplantation

Patients who undergo renal transplantation require complex care that involves a diligent, multidisciplinary approach.

An Update on Robotic-Assisted Partial Nephrectomy

Short-term outcomes from early institutional experiences have confirmed the safety and feasibility of RPN, even for anatomically complex tumors.

A Nephrologic Perspective on the Management of Gout

A Nephrologic Perspective on the Management of Gout

Gout is increasingly recognized in patients with chronic kidney disease, but the proper dosing regimen for traditional agents has not been well-studied in this patient group.

CROWNWeb: Expanding Facilities' Ability to Report Patient-Based Data

CROWNWeb: Expanding Facilities' Ability to Report Patient-Based Data By

An overview of how CROWNWeb, CMS' Web-based end-stage renal disease (ESRD) data-collection system, has been updated with vaccination, hospitalization, and infection data to help CMS, the ESRD Networks, and dialysis facilities better analyze patient care efforts.

Examining the Pharmacoeconomics of Advanced Prostate Cancer

Examining the Pharmacoeconomics of Advanced Prostate Cancer

In determining prostate cancer treatment, physicians should discuss preferences, values, and expectations with patients, including life expectancy, adverse events, and costs

Hyponatremia: An Update on the Management of SIADH

Hyponatremia: An Update on the Management of SIADH

Therapeutic options for SIADH have been significantly enhanced with the introduction of specific vasopressin receptor antagonists

PSA Testing: Why the U.S. and Europe Differ

By

Solid evidence for a survival benefit from PSA screening for prostate cancer is lacking, but the practice is more widespread in the United States than in many European countries.

Dialysis in the U.S. and Abroad

Dialysis in the U.S. and Abroad By

Four nephrologists weigh in about the substantive differences in dialysis implementation in this country and worldwide.

Issues in Hypertension: An Interview with George Bakris, MD

Issues in Hypertension: An Interview with George Bakris, MD By

George Bakris, MD, spoke about various aspects of treating hypertension in patients with chronic kidney disease.

Intermittent ADT in Prostate Cancer: A Step-by-Step Approach

Intermittent ADT in Prostate Cancer: A Step-by-Step Approach

In select patients, use of intermittent therapy does not appear to negatively affect overall survival and is associated with fewer adverse events.

Prostatitis and Chronic Pelvic Pain Syndrome: An Update

Prostatitis and Chronic Pelvic Pain Syndrome: An Update

Etiology and treatment are clearly defined for infectious prostatic syndromes, but not for chronic pelvic pain syndrome.

Invading a Patient's Privacy Costs a Physician

Invading a Patient's Privacy Costs a Physician By

Dr. D, 29, was the chief resident finishing up his final year of a surgical residency in a prestigious hospital. Life was golden for the young doctor. He had been a bright and talented student in medical school, and stood out during his residency.

Cause-Specific Outcomes Associated with Hypovitaminosis D

Cause-Specific Outcomes Associated with Hypovitaminosis D

The complex biological actions of vitamin D suggest its involvement in various pathologies. (This is the second of a two-part CME article.)

Vitamin D and Clinical Outcomes in Patients With and Without CKD: Part I

Vitamin D and Clinical Outcomes in Patients With and Without CKD: Part I

Research has shown that vitamin D deficiency has a role in the progressive loss of kidney function as well as increased mortality.

Relationships of Testosterone and Prostate Cancer: A 2011 Perspective

Relationships of Testosterone and Prostate Cancer: A 2011 Perspective

A history of prostate cancer has generally been a contraindication for testosterone therapy, but the clinical model may be changing.

Lessons Lived: Ailments Get Personal for Some Docs

Lessons Lived: Ailments Get Personal for Some Docs By

Physicians' experiences as patients may cause them to reflect on the medical care they provide.

IgA Nephropathy: An Update on Diagnosis and Management

IgA Nephropathy: An Update on Diagnosis and Management

Following a renal biopsy diagnosis of IgA nephropathy, clinicians need to estimate prognosis and design an appropriate short- and long-term treatment strategy.

Classifying Histologic Subtypes of Renal Cell Carcinoma

Classifying Histologic Subtypes of Renal Cell Carcinoma

Recent advances in understanding genetic changes associated with kidney tumor 
formation have led to new pathologic classifications.

Managing Patients Following a Negative Prostate Biopsy

Managing Patients Following a Negative Prostate Biopsy

This article addresses the issues that must be understood to navigate the scenario posed by patients that have had a prior negative biopsy.

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

Parathyroid Hormone, Alkaline Phosphatase and Fibroblast Growth Factor 23

The management of chronic kidney disease-mineral bone disorder (CKD-MBD) is central to the care of patients with kidney disease. Key to these efforts is the availability of clinically accessible biomarkers that can help distinguish between a wide variety of bone and mineral disturbances related to kidney failure.

Standardization: The Future of Testosterone Testing

By

Endocrinologist William Rosner, MD, Professor of Medicine at Columbia University in New York, explains to Renal & Urology News what impending testosterone-testing standardization—and the current lack of it—means to urology practice and research.

Peritoneal Dialysis: Does It Have a Brighter Future?

By

Regulatory changes have enhanced clinicians' ability to recommend the modality, which offers long-term survival similar to that of hemodialysis.

Have MD, Will Travel: Locum Tenens Docs Today

Have MD, Will Travel: Locum Tenens Docs Today By

Fed up with the frustrations of private practice, some urologists and nephrologists have chosen the life of an itinerant professional.

Unique Treatment Raises Tricky Bioethical Issues

Unique Treatment Raises Tricky Bioethical Issues By

Vaccine for advanced castration-resistant prostate cancer prolongs life by a median of four months, but at an extremely high cost.

The Ethics of Discontinuing Dialysis

The Ethics of Discontinuing Dialysis By

One practitioner's perceived good deed for a dying patient could be another's definition of homicide.